COVID-19 trials registries data warehouse

 Return to trial list

Trial - CTRI/2020/12/029614


Column Value
Trial registration number CTRI/2020/12/029614
Full text link
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

First author
Last imported at : Nov. 26, 2021, 10:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Dr Mahendra Kumar Garg

Contact
Last imported at : Nov. 26, 2021, 10:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

mkgargs@gmail.com

Registration date
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2020-12-07

Recruitment status
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not recruiting

Study design
Last imported at : Nov. 18, 2021, 7:33 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

RCT

Allocation
Last imported at : Nov. 18, 2021, 7:33 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Randomized

Design
Last imported at : Nov. 18, 2021, 7:33 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Parallel

Masking
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Open label

Center
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

single-center

Study aim
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Treatment

Inclusion criteria
Last imported at : Nov. 26, 2021, 10:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Part I: Patients >18 years of age diagnosed as COVID-19 positive by reverse transcriptase Polymerase Chain Reaction (RT PCR) and are having mild COVID-19 with cough or dyspnea or both with room air saturation is within normal limits ( > 94%). <br/ >Part II: Patients >18 years of age diagnosed as COVID-19 positive by reverse transcriptase Polymerase Chain Reaction (RT PCR) and PaO2/FiO2 of 200-350 as assessed by arterial blood gas (ABG) analysis. <br/ >

Exclusion criteria
Last imported at : Nov. 26, 2021, 10:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

1.Any patient requiring immediate intubation and ventilatory care <br/ >2.Hemodynamic instability BP < 90/60 mm Hg or on inotropic support <br/ >3.Elevated intracranial pressure <br/ >4.Altered sensorium or history of seizures <br/ >5.Any psychiatric comorbidity <br/ >6.Pregnancy <br/ >7.Patients at high risk of requiring CPR or defibrillation (known arrhythmias) <br/ >8.Known chronic cardiopulmonary diseases like Bronchial asthma (with history of wheeze or bronchodilator use), chronic obstructive pulmonary disease, interstitial lung disease (aassessed by Computed Tomography (CT) Chest), congestive heart failure (clinical assessment), and obstructive sleep apnea (assessed with Epworth Sleepiness scale). <br/ >9.Any recent acute condition like pulmonary embolism, acute coronary syndrome, deep vein thrombosis, intestinal obstruction or cerebrovascular accident. <br/ >

Number of arms
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2

Funding
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

All India Institute of Medical Sciences Jodhpur

Inclusion age min
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

18

Inclusion age max
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

100

Countries
Last imported at : Nov. 26, 2021, 10:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

India

Type of patients
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Moderate/severe disease at enrollment

Severity scale
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

80

primary outcome
Last imported at : Nov. 26, 2021, 10:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Primary outcome â?? I: Time to becoming symptom free (cough; breathlessness. <br/ >Primary outcome â?? II: Change in PaO2/FiO2 ratio in both groups will be compared. <br/ >Timepoint: Primary outcome â?? I: Time to becoming symptom free (cough; breathlessness; assessed at 6th day. <br/ >Primary outcome â?? II: Change in PaO2/FiO2 ratio in both groups will be compared at end of 6th day. <br/ >

Notes
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Phase
Last imported at : Jan. 15, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Phase 2

Arms
Last imported at : Nov. 26, 2021, 10:30 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

[{"arm_notes": "", "treatment_id": 430, "treatment_name": "Early liberal oxygen therapy", "treatment_type": "Respiratory support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]